Ruxolitinib as First-Line Treatment in Secondary Hemophagocytic Lymphohistiocytosis: A Second Experience
American Journal of Hematology - United States
doi 10.1002/ajh.25063
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 24, 2018
Authors
Publisher
Wiley